Interleukin-17D Attenuates OVA-induced Airway Inflammation and Remodeling Partially via the CD93 Receptor
Our findings suggest that IL-17D could play a protective role in asthmatic airway inflammation and remodeling, partially through the CD93 receptors. These results highlight IL-17D as a potential therapeutic target for asthma management.
Authors
- Liang Dong (ORCID: https://orcid.org/0000-0001-7707-9982)
- Chengfang Yao (ORCID: https://orcid.org/0000-0001-8860-2206)
- Qian Qi (ORCID: https://orcid.org/0000-0002-5813-3194)
- Jianwen Fei
- Yun Pan (ORCID: https://orcid.org/0000-0002-5014-0322)
- Changjuan Xu (ORCID: https://orcid.org/0000-0001-8414-2986)
- Ying Wang
- Ju Liu (ORCID: https://orcid.org/0000-0001-9932-2613)
- Shuochuan Shi
- Rong Zeng (ORCID: https://orcid.org/0000-0003-1320-8815)
- Jintao Zhang (ORCID: https://orcid.org/0000-0002-1309-6836)
- Xiaofei Liu (ORCID: https://orcid.org/0000-0002-7285-7578)
- Li Li (ORCID: https://orcid.org/0009-0001-5767-9662)
- Zhi Jian Guo
Institutions
- Shandong University (CN)
- Tianjin Infectious Diseases Hospital (CN)
- Shandong Provincial Hospital (CN)
- Yantaishan Hospital (CN)
- Shandong Provincial QianFoShan Hospital (CN)
- Shandong First Medical University (CN)
- Tianjin haihe hospital (CN)
Publication Details
- Journal
- Allergy Asthma and Immunology Research
- Published
- 2025-01-01
- DOI
- https://doi.org/10.4168/aair.2025.17.5.592
- Primary Topic
- Pediatric health and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- China International Medical Foundation
- National Science and Technology Major Project
- Key Technology Research and Development Program of Shandong